We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+3.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$7.23B
AUM Growth
+$298M
(+4.3%)
Cap. Flow
+$149M
Cap. Flow
% of AUM
2.07%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
1,100
New
151
Increased
415
Reduced
333
Closed
164
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$40.6M |
| 2 |
Autodesk
ADSK
|
+$38.8M |
| 3 |
Intuit
INTU
|
+$37.1M |
| 4 |
Ecolab
ECL
|
+$35.6M |
| 5 |
Coca-Cola
KO
|
+$35.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$51.9M |
| 2 |
EOG Resources
EOG
|
+$33.8M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$32M |
| 4 |
Microsoft
MSFT
|
+$29.8M |
| 5 |
Ford
F
|
+$29.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.67% |
| 2 | Financials | 17.68% |
| 3 | Consumer Discretionary | 13.74% |
| 4 | Industrials | 11.53% |
| 5 | Healthcare | 11.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
iShares Russell 2000 Growth ETF
IWO
$14.5B
| $1.1M | 0.02% |
5,480
| – | – |
|
|
ECOM
627
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $1.1M | 0.02% |
125,481
-40,430
| -24% | -$419K |
|
628
First Merchants
FRME
$2.72B
| $1.1M | 0.02% |
28,962
+8,890
| +44% | +$326K |
|
629
Ryman Hospitality Properties
RHP
$8.4B
| $1.08M | 0.01% |
13,300
+1,660
| +14% | +$136K |
|
|
VAR
630
DELISTED
Varian Medical Systems, Inc.
VAR
| $1.06M | 0.01% |
7,820
-490
| -6% | -$65.5K |
|
631
Shutterstock
SSTK
$205M
| $1.06M | 0.01% |
27,079
-170
| -0.6% | -$7.06K |
|
632
First Commonwealth Financial
FCF
$2.12B
| $1.06M | 0.01% |
78,610
+43,510
| +124% | +$574K |
|
|
USX
633
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $1.05M | 0.01% |
205,322
-18,689
| -8% | -$114K |
|
634
Eversource Energy
ES
$28.2B
| $1.05M | 0.01% |
13,870
-490
| -3% | -$35.9K |
|
|
MRC
635
DELISTED
MRC Global
MRC
| $1.05M | 0.01% |
+61,300
| New | +$1.03M |
|
|
NEX
636
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $1.04M | 0.01% |
+155,179
| New | +$1.45M |
|
|
VRS
637
DELISTED
Verso Corporation
VRS
| $1.04M | 0.01% |
54,605
-24,630
| -31% | -$498K |
|
638
Minerva Neurosciences
NERV
$188M
| $1.04M | 0.01% |
23,039
+6,493
| +39% | +$325K |
|
|
CSGS
639
DELISTED
CSG Systems International
CSGS
| $1.01M | 0.01% |
20,795
-28,712
| -58% | -$1.31M |
|
640
First American
FAF
$7.67B
| $1.01M | 0.01% |
18,800
-2,000
| -10% | -$109K |
|
641
Public Service Enterprise Group
PEG
$39.8B
| $1.01M | 0.01% |
17,130
-60
| -0.3% | -$3.58K |
|
642
WEX
WEX
$6.11B
| $1M | 0.01% |
4,810
+1,210
| +34% | +$244K |
|
|
SPN
643
DELISTED
Superior Energy Services, Inc.
SPN
| $991K | 0.01% |
+76,246
| New | +$2.24M |
|
644
Kroger
KR
$34.8B
| $989K | 0.01% |
45,540
+2,400
| +6% | +$58.4K |
|
645
IMAX
IMAX
$2.38B
| $984K | 0.01% |
48,726
-300
| -0.6% | -$6.77K |
|
646
Procter & Gamble
PG
$343B
| $979K | 0.01% |
8,930
+550
| +7% | +$58.6K |
|
647
Peapack-Gladstone Financial
PGC
$822M
| $978K | 0.01% |
34,764
+1,040
| +3% | +$28.8K |
|
|
HTLF
648
DELISTED
Heartland Financial USA, Inc.
HTLF
| $968K | 0.01% |
21,630
+6,800
| +46% | +$300K |
|
649
Plexus
PLXS
$6.81B
| $954K | 0.01% |
16,341
| – | – |
|
|
LSI
650
DELISTED
Life Storage, Inc.
LSI
| $947K | 0.01% |
+14,940
| New | +$959K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q2 2019 Portfolio in Review
As of Q2 2019, Jacobs Levy Equity Management held 1,100 positions worth $7.23B, up 4.3% from $6.93B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Jacobs Levy Equity Management's Q2 2019 filing shows 151 new, 415 increased, 333 reduced and 164 closed positions. Its largest new stake was Biogen: 175,817 shares worth $41.1M. The largest sale was Allergan plc, an estimated $51.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Jacobs Levy Equity Management's largest Q2 2019 buy was Biogen: 175,817 shares worth $41.1M.
- Jacobs Levy Equity Management added most to Ecolab in Q2 2019, an estimated $35.6M increase.
- Jacobs Levy Equity Management's biggest Q2 2019 reduction was EOG Resources, cutting an estimated $33.8M.
- Jacobs Levy Equity Management fully exited Allergan plc in Q2 2019, selling an estimated $51.9M.
- Jacobs Levy Equity Management's ten largest holdings make up 15% of its $7.23B portfolio in Q2 2019.
- Jacobs Levy Equity Management opened 151 new positions and closed 164 in Q2 2019.
- Jacobs Levy Equity Management's portfolio value rose 4.3% quarter-over-quarter to $7.23B.
Based on Jacobs Levy Equity Management's 13F filing for Q2 2019, filed 13 Aug 2019.